Results 151 to 160 of about 107,669 (285)

WHEN WILL THE NEW TUBERCULOSIS VACCINE APPEAR?

Журнал микробиологии, эпидемиологии и иммунобиологии, 2015
The problem of tuberculosis prophylaxis remains actual for many countries of the world including Russia. The search of candidates for substitution of the only authorized BCG vaccine has been ongoing for some time, because it does not prevent reactivation
A. M Korolyuk, L. A Zazimko, S. V Petrovsky   +2 more
doaj  

The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries. [PDF]

BMJ Glob Health, 2023
Portnoy A, Clark RA, Weerasuriya CK, Mukandavire C, Quaife M, Bakker R, Garcia Baena I, Gebreselassie N, Zignol M, Jit M, White RG, Menzies NA.   +11 more
europepmc   +1 more source

Therapeutic Opportunities in Infectious Diseases: Highlights from the Society of Medicines Research Symposium, held on March 14th 2013 at the National Heart & Lung Institute, London, UK [PDF]

, 2013
Alderton, W K, Anderson, Rosaleen, Collingwood, S P, Pryde, D C   +3 more
core   +1 more source

Developing and Distributing Essential Medicines to Poor Countries: The DEFEND Proposal [PDF]

The poorest nations of the world suffer from extreme disease burdens, which go largely untreated because weak incomes and the prevailing system of intellectual property rights fail to provide sufficient incentives to develop new treatments and distribute
Ganslandt, Mattias, Maskus, Keith E., Wong, Eina V.   +2 more
core  

Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines

, 2017
Stephanie A. Harris, Andrew White, Lisa Stockdale, Rachel Tanner, Laura Sibley, Charlotte Sarfas, Joel N. Meyer, Jonny Peter, Matthew K. O’Shea, Zita-Rose Manjaly Thomas, Ali Hamidi, Iman Satti, Mike Dennis, Helen McShane, Sally Sharpe   +14 more
openalex   +1 more source

Digital Health and Fiscal Credibility in Low‐ and Middle‐Income Countries: A Scoping Review of Practice‐Based Evidence

Journal of Evaluation in Clinical Practice, Volume 32, Issue 1, February 2026.
ABSTRACT Rationale Digital health is widely promoted in low‐ and middle‐income countries (LMICs), yet investment is often constrained by fiscal rules and borrowing limits. Policymakers also struggle to explain how digital health improves fiscal sustainability and, by proxy, fiscal credibility, creating a gap between technical promise and investable ...
Samuel Atiku, Olufisayo Olakotan
wiley   +1 more source

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study. [PDF]

PLoS Med, 2023
Portnoy A, Clark RA, Quaife M, Weerasuriya CK, Mukandavire C, Bakker R, Deol AK, Malhotra S, Gebreselassie N, Zignol M, Sim SY, Hutubessy RCW, Baena IG, Nishikiori N, Jit M, White RG, Menzies NA.   +16 more
europepmc   +1 more source

A major T cell antigen of Mycobacterium leprae is a 10-kD heat-shock cognate protein. [PDF]

, 1992
Several mycobacterial antigens, identified by monoclonal antibodies and patient sera, have been found to be homologous to stress or heat-shock proteins (hsp) defined in Escherichia coli and yeast.
Alland, D, Bajardi, AC, Bloom, BR, Brennan, PJ, Convit, J, Fan, XD, Grisso, CL, Hunter, SW, Mehra, V, Sieling, PA   +9 more
core  

Cortisol Regulates PD‐1 and IL‐12 in Canine Leishmaniasis

Parasite Immunology, Volume 48, Issue 2, February 2026.
ABSTRACT Canine visceral leishmaniasis (CanL) is a tropical zoonosis caused by Brazil's protozoan Leishmania (L.) infantum. Disorders in the hypothalamic–pituitary–adrenal (HPA) axis have been reported in human and experimental visceral leishmaniasis, but not yet in canine leishmaniasis.
Lucas Takeshi Siqueira Ito, Gisele Mitsue Umino, Mayla Abbas Guimarães, Bianca Maciel Marques de Souza, Sofia Furrier Soares, Luiz Eduardo Amador Loiola Pereira, Valéria Marçal Felix de Lima   +6 more
wiley   +1 more source

Vaccines Directed Against Microorganisms or Their Products Present During Biofilm Lifestyle: Can We Make a Translation as a Broad Biological Model to Tuberculosis? [PDF]

, 2016
Mario Alberto Flores‐Valdez
openalex   +1 more source